今海医疗科技(02225.HK) 在去年12月9日被证监点名指股权高度集中。公司在周二(12月31日)公布，自证监会公告刊发以来，已实施一项投资者关系计划，包括举行现有股东大会、增加与国内及国际投资银行、经纪人及其他机构投资者的互动，并提升公司于投资及金融界、中介及机构分析师中的形象。
公司指，每股已发行及未发行股份已在12月12日后拆细为四股每股面值0.0025元之普通股，以相应减少每股股份之成交价。另外，董事会亦已议决授出购股权以认购1.3亿股股份，将进一步扩阔公司股东基础。(vc/da)(港股报价延迟最少十五分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.